Virtual Seminar: Tumor Intrinsic and Extrinsic Mechanisms Promoting Brain Metastasis
Diana Cittelly, Ph.D.
Associate Professor of Pathology
University of Colorado Anschutz Medical Campus
Virtual Pioneers in Biomedical Research Seminar: Tumor Intrinsic and Extrinsic Mechanisms Promoting Brain Metastasis
Jan. 28, 2022
11:00 a.m. to 12:00 p.m.
About this Seminar
Brain metastases have emerged as an unmet clinical need in cancer research. Recent advances show that cancer cells adapt to unique features and cells within the brain microenvironment, and that paracrine mechanisms initiated in the brain niche are critical for metastatic colonization and outgrowth. With a focus on breast-to-brain metastasis, this seminar will show how estradiol acts on estrogen-receptor positive (ER+) astrocytes leading to the upregulation of growth factors and chemokines than in a paracrine manner, promote brain metastatic traits in breast cancer cells lacking ERs (or triple-negative breast cancer). This seminar will explore a novel function of ovarian and brain-derived estrogens in the modulation of neuroinflammatory responses during brain metastatic progression.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Seminar: Precision Medicine of Biological Drugs for Brain Cancer , homeDec. 7, 2023, 11 a.m. | Professor, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine | Seminar | Children's National Research and Innovation Campus
-
Home Item
In Person at CNRIC: Hyperactivation of an RNA Binding Protein by Cancer-associated Mutations , homePOSTPONED: Dec. 8, 2023, 11:00 a.m., Collaboratory, Children's National Research and Innovation Campus, Washington, D.C. | Daniel Dominguez, Ph.D., Assistant Professor, Pharmacology, UNC School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group
-
Home Item
In Person Seminar: An Epigenome Atlas of the Embryonic Mouse Brain to Study Interneuron Neurogenesis in Normal Development and Disease Models , homeDec. 15, 2023, 11:00 a.m. | Timothy Petros, Ph.D., Investigator, Unit on Cellular and Molecular Neurodevelopment, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
In Person Seminar: Quantitative Proteomics for Understanding Epigenetic Cancer Mechanisms , homeJan. 12, 2024, 11 a.m. | Ben Garcia, Ph.D., Raymond H. Wittcoff Distinguished Professor and Head, Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group
-
Home Item
In Person Seminar: Building and Maintaining Biological Tubes , homeJan. 19, 2024, 11 a.m. | Ondine Cleaver, Ph.D., Professor, Molecular Biology, University of Texas Southwestern Medical Center | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Long Covid: the Lasting Legacy of the COVID-19 Pandemic , homeJan. 25, 2024, 5:30 p.m. (Reception at 5 p.m.) | Ziyad Al-Aly, M.D., FASN, Chief of Research and Development Service, Director, Clinical Epidemiology Center, VA St. Louis Health Care Systems | Maury Strauss Distinguished Public Lecture